Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease

Kidney International

Volumn 66, Issue 4, 2004, Pages 1527-1534

  Evans, Allan M ^a   Faull, Randall J ^b   Nation, Roger L ^b   Prasad, Shilpanjali ^b   Elias, Tony ^b   Reuter, Stephanie E ^b   Fornasini, Gianfranco ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b NONE

Author keywords

Acetyl L carnitine; End stage renal disease; Hemodialysis; L carnitine; Plasma; Skeletal muscle

Indexed keywords

CARNITINE; LEVACECARNINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DIALYSIS; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MALE; MUSCLE LEVEL; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 4644278071     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00916.x     Document Type: Article

References (32)

1. HOPPEL C: The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 41(Suppl 4):S4-S12, 2003
2. EVANS A: Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 41 (Suppl 4):S13-S26, 2003
3. EVANS AM, FORNASINI G: Pharmacokinetics of L-carnitine. Clin Pharmacokinet 42:941-967, 2003
4. BARTEL LL, HUSSEY JL, SHRAGO E: Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy. Am J Clin Nutr 34:1314-1320, 1981
5. GUARNIERI G, TOIGO G, CRAPESI L, et al: Carnitine metabolism in chronic renal failure. Kidney Int (Suppl 22):S116-S127, 1987
6. RODRIGUEZ-SEGADE S, ALONSO DE LA PEÑA C, PAZ JM, et al: Carnitine deficiency in haemodialysed patients. Clin Chim Acta 159:249-256, 1986
7. RODRIGUEZ-SEGADE S, ALONSO DE LA PEÑA C, PAZ M, et al: Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency. Ann Clin Biochem 23:671-675, 1986
8. AHMAD S: L-carnitine in dialysis patients. Semin Dial 14:209-217, 2001
9. DEBSKA-SLIZIEÑ A, KAWECKA A, WOJNAROWSKI K, et al: Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients. Int J Artif Organs 23:90-96, 2000
10. SAKURAUCHI Y, MATSUMOTO Y, SHINZATO T, et al: Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis 32:258-264, 1998
11. GOLPER TA, AHMAD S: L-carnitine administration to hemodialysis patients: Has its time come? Semin Dial 5:94-98, 1992
12. EKNOYAN G, LATOS DL, LINDBERG J: Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. Am J Kidney Dis 41:868-876, 2003
13. EVANS AM, FAULL R, FORNASINI G, et al: Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 68:238-249, 2000
14. LONGO A, BRUNO G, CURTI S, et al: Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivitization with L-aminoanthracene. J Chromatogr B Biomed Appl 686:129-139, 1996
15. CEDERBLAD G, LINDSTEDT S, LUNDHOLM K: Concentration of carnitine in human muscle tissue. Clin Chim Acta 53:311-321, 1974
16. BERTOLI M, BATTISTELLA PA, VERGANI L, et al: Carnitine deficiency induced during hemodialysis and hyperlipidemia: Effect of replacement therapy. Am J Clin Nutr 34:1496-1500, 1981
17. GOLPER TA, WOLFSON M, AHMAD S, et al: Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 38:904-911, 1990
18. HIATT WR, KOZIOL BJ, SHAPIRO JI, BRASS EP: Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 41:1613-1619, 1992
19. LESCHKE M, RUMPF KW, EISENHAUER T, et al: Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int (Suppl 16):S143-S146, 1983
20. WANNER C, FÖRSTNER-WANNER S, SCHAEFFER G, et al: Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol 6:206-211, 1986
21. WANNER C, HÖRL WH: Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects. Nephron 50:89-102, 1988
22. BELLINGHIERI G, SAVICA V, MALLAMACE A, et al: Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 38:523-531, 1983
23. GLÖGGLER A, BULLA M, PUCHSTEIN C, et al: Plasma and muscle carnitine in healthy and hemodialyzed children. Child Nephrol Urol 9:277-282, 1988-1989
24. HARPER P, WADSTRÖM C, CEDERBLAD G: Carnitine measurements in liver, muscle tissue, and blood in normal subjects. Clin Chem 39:592-599, 1993
25. MOORTHY AV, ROSENBLUM M, RAJARAM R, SHUG AL: A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am J Nephrol 3:205-208, 1983
26. SAVICA V, BELLINGHIERI G, DI STEFANO C, et al: Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 35:232-236, 1983
27. SIAMI G, CLINTON ME, MRAK R, et al: Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 57:306-313, 1991
28. KURTIN PS: Carnitine metabolism and usage in chronic dialysis patients. Semin Dial 3:166-170, 1990
29. FAGHER B, CEDERBLAD G, ERIKSSON M, et al: L-Carnitine and haemodialysis: Double blind study on muscle function and metabolism and peripheral nerve function. Scand J Clin Lab Invest 45:169-178, 1985
30. MINGARDI G, BIZZI A, CINI M, et al: Carnitine balance in hemodialyzed patients. Clin Nephrol 13:269-270, 1980
31. REBOUCHE CJ, ENGEL AG: Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport. J Clin Invest 73:857-867, 1984
32. BOHMER T, BERGREM H, EIKLID K: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1:126-128, 1978